PROVECTUS BIOPHARMACEUTICALS, INC.

Industry: Pharmaceuticals (See others in industry)

Address:
800 S. Gay Street Suite 1610
Knoxville, TN, 37929
Phone: 866-594-5999

Filings

Date Type Incremental Cash Raw Filing
2024-07-17 New $0 SEC link
2022-10-28 New $317,500 SEC link
2021-08-30 New $200,000 SEC link
2014-10-15 New $0 SEC link
2014-04-17 New $3,373,250 SEC link
2013-09-26 New $7,798,037 SEC link
2013-03-08 New $2,550,000 SEC link
2012-11-19 New $2,034,675 SEC link
2012-08-03 New $2,077,796 SEC link
2012-03-22 New $499,999 SEC link
2011-05-05 New $4,615,300 SEC link
2010-05-13 New $200,000 SEC link
2010-04-06 New $1,271,900 SEC link
2010-03-26 Amended $3,106,151 SEC link
2010-03-24 New $7,937,499 SEC link
2009-08-07 Amended $1,795,176 SEC link
2009-06-30 New $2,712,000 SEC link
2007-06-06 Paper Filing Unknown Not Available
2006-10-30 Paper Filing Unknown Not Available
2006-10-04 Paper Filing Unknown Not Available

Directors and Executives (Current and Past)

Name Role
Webster Bailey Director
Peter R. Culpepper Executive
Craig Dees Director, Executive
H. Craig Dees Director, Executive
Stuart Fuchs Director
Bruce Horowitz Director, Executive
Jan Koe Director
John Lacey, Iii Director
Kelly M. Mc Masters Director
Edward Pershing Director
Ed Pershing Director
Heather Raines Executive
Dominic Rodrigues Director
Tim Scott Executive
Timothy C. Scott Director, Executive
Alfred E. Smith Iv Director
Eris A. Wachter Executive
Eric Wachter Executive